ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2674

Identifying Phenotype Clusters in Systemic Lupus Erythematosus By Damage Cluster

Ga Young Ahn1, Jiyoung Lee2, Eunji Ha3, Kwangwoo Kim3, Hyoungyoung Kim1, Ji Soong Kim1, Bora Nam1, Juyeon Kang1, Hyuk-Hee Kwon1, So-Young Bang1, Hye-Soon Lee1 and Sang-Cheol Bae1, 1Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 2Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, Korea, Republic of (South), 3Biology, Kyung Hee University, Seoul, Korea, Republic of (South)

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: high risk, morbidity and mortality, registry and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster III: Treatment

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disease with complex genetic background. Recently, subphenotype in SLE has influenced dialogue on discussing the genetic background, disease course, outcomes and treatment. The objective of this study is to identify phenotype clusters within a SLE cohort patients, and compare the genetic risk score (GRS), clinical manifestations and mortality between clusters.

Methods: This is a single center, descriptive study of from Hanyang BAE lupus Cohort. Patients whose disease duration is less than 5 years were excluded to minimize potential confounding effects of disease duration. Mortality data were derived in connection with data from the Korean National Statistics Office. Patients were grouped into 3 clusters based on SLICC Damage Index (SDI) using K-mean cluster analysis. Clinical characteristics were compared using ANOVA and Tukey’s test.

Results: In 1130 analyzed patients, musculoskeletal damage was the most prevalent (20.2%), followed by ocular (11.4%), renal (10.5%) and neuropsychiatric damage (10.2%). Three separate damage clusters were identified, each with significantly different damage manifestations. Cluster 1 (n=824) showed the least damage profile. Cluster 2 (n=195) was represented by the predominance of renal damage (55.4%), with prevalent ocular (58.0%), musculoskeletal (29.2%) damage and diabetes mellitus (8.2%). Cluster 3 (n=111) was characterized by neuropsychiatric damage (100%) with musculoskeletal (35.1%) and pulmonary damage (17.1%). Age of onset of SLE and autoantibody positivity were similar among clusters. Cluster 2, represented by prevalent renal and glucocorticoid associated damages, showed higher adjusted mean SLEDAI score (AMS) (Mean ± SD, 6.7 ± 4.8) than other two clusters. Cluster 3 distinguished by neuropsychiatric damage showed the highest mortality among three clusters. However, GRS showed no difference between 3 clusters after Tukey’s test.

Conclusion: We identified different patterns of damage manifestations in a large cohort of SLE patients. Renal and neuropsychiatric damage were the two distinct domain of damage that classified patients into 3 clinically meaningful clusters. Patients in cluster 2 (prevalent renal and glucocorticoid associated damage) had the highest AMS. The highest mortality was recognized in cluster with prevalent neuropsychiatric damage. However, GRS showed no difference between clusters Further studies assessing comprehensive subphenotypes are needed.


Disclosure: G. Y. Ahn, None; J. Lee, None; E. Ha, None; K. Kim, None; H. Kim, None; J. S. Kim, None; B. Nam, None; J. Kang, None; H. H. Kwon, None; S. Y. Bang, None; H. S. Lee, None; S. C. Bae, None.

To cite this abstract in AMA style:

Ahn GY, Lee J, Ha E, Kim K, Kim H, Kim JS, Nam B, Kang J, Kwon HH, Bang SY, Lee HS, Bae SC. Identifying Phenotype Clusters in Systemic Lupus Erythematosus By Damage Cluster [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/identifying-phenotype-clusters-in-systemic-lupus-erythematosus-by-damage-cluster/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identifying-phenotype-clusters-in-systemic-lupus-erythematosus-by-damage-cluster/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology